We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Axon Enterprise Inc | NASDAQ:AXON | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.31 | 0.41% | 318.06 | 318.18 | 318.36 | 321.00 | 316.64 | 319.24 | 110,748 | 18:08:42 |
Bermuda
|
|
001-37418
|
|
98-1333697
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File No.)
|
|
(I.R.S. Employer Identification No.)
|
|
Clarendon House - 2 Church Street
Hamilton HM 11
Bermuda
|
|
Not Applicable
|
|
|
(Address of principal executive office)
|
|
(Zip Code)
|
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
|
Press Release of Axovant Sciences Ltd., dated February 14, 2017, “Axovant Sciences Announces Dementia Pipeline Updates and Reports Financial Results for the Third Fiscal Quarter and Nine Months Ended December 31, 2016”
|
|
Axovant Sciences Ltd.
|
||
|
|
||
|
|
||
Date:
|
|
By:
|
/s/ Gregory Weinhoff
|
February 14, 2017
|
|
Name:
|
Gregory Weinhoff
|
|
|
Title:
|
Principal Financial Officer
|
|
|
|
|
Exhibit
|
|
|
|
Number
|
|
Description
|
|
|
|
|
|
99.1
|
|
|
Press Release of Axovant Sciences Ltd., dated February 14, 2017, “Axovant Sciences Announces Dementia Pipeline Updates and Reports Financial Results for the Third Fiscal Quarter and Nine Months Ended December 31, 2016”
|
1 Year Axon Enterprise Chart |
1 Month Axon Enterprise Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions